Zoledronic acid is rated as one of the safest and most effective medicines by the World Health Organization. The osteoporosis drug also makes it on the WHO’s List of Essential Medicines. In a report published in the medical journal Lung Cancer, doctors from the University of Alabama found that one third of the mesothelioma patients studied received at least some benefit while none of the patients reported negative side effects.
The study covered eight individuals with late stage mesothelioma. The median age of the patient was 62 and 6 of the patients studied had epithelioid mesothelioma – the most common form. All of the patients in the study had failed to respond to other treatments or were too ill to be considered for surgical treatments.
The zoledronic acid did not have a significant impact on mesothelioma survival times however it did shrink or stop tumor growth in over one third of the patients. It took an average of two months for the tumors to start growing again. Remarkably, none of the patients were subjected to negative side effects. Compared to treatments such as chemotherapy which can carry severe negative effects and toxicity levels the zoledronic acid’s benefits are even more apparent. Dr. Jamil, the head researcher on the study stated that, “Zoledronic acid shows modest clinical activity without significant toxicity in patients with advanced malignant pleural mesothelioma.”
The Paul Law Firm advocates for victims of asbestos-related diseases. If you or a loved one is suffering from mesothelioma, call the Paul Law Firm. With over 2.5 billion dollars collected for victims of asbestos exposure, we have the knowledge and the experience to fight for you. We also understand that fighting doesn’t just happen in the courtroom. It also happens in a lab where we are fighting for a cure. Check out the Mesothelioma Research Foundation of America here.
Call us today at 1-855 88 LEGAL (885-3425) or contact us online to discuss your case with one of our experienced mesothelioma lawyers